(Q39786229)

14 September 2017

Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells (English)

1 reference

14 September 2017

0 references

1 reference

G-Y Jang

1

1 reference

14 September 2017

J-H Jeon

2

1 reference

14 September 2017

S-Y Cho

3

1 reference

14 September 2017

D-M Shin

4

1 reference

14 September 2017

C-W Kim

5

1 reference

14 September 2017

E M Jeong

6

1 reference

14 September 2017

H C Bae

7

1 reference

14 September 2017

T W Kim

8

1 reference

14 September 2017

S-H Lee

9

1 reference

14 September 2017

Y Choi

10

1 reference

14 September 2017

D-S Lee

11

1 reference

14 September 2017

S-C Park

12

1 reference

14 September 2017

I-G Kim

13

1 reference

14 September 2017

language of work or name

English

0 references

publication date

19 October 2009

1 reference

14 September 2017

1 reference

14 September 2017

29

1 reference

14 September 2017

3

1 reference

14 September 2017

356-367

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2009.342

14 September 2017

0 references

cites work

Nuclear factor-kappaB: the enemy within

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Two isoforms of tissue transglutaminase mediate opposing cellular fates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Tying it all together: epigenetics, genetics, cell cycle, and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Exploiting tumour hypoxia in cancer treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Oxygen deprivation induced cell death: an update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Targeting gene expression to hypoxic tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Gene disruption of tissue transglutaminase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Measurement of oxidative stress in cells exposed to hypoxia and other changes in oxygen concentration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Transglutaminase 2: an enigmatic enzyme with diverse functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

HIF-1 as a target for drug development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

A novel function of tissue-type transglutaminase: protein disulphide isomerase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Calcium signaling stimulates translation of HIF-alpha during hypoxia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Differential incorporation of biotinylated polyamines by transglutaminase 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Different inhibition characteristics of intracellular transglutaminase activity by cystamine and cysteamine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Direct Transcriptional Up-regulation of Cyclooxygenase-2 by Hypoxia-Inducible Factor (HIF)-1 Promotes Colorectal Tumor Cell Survival and Enhances HIF-1 Transcriptional Activity during Hypoxia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

GTP hydrolysis by guinea pig liver transglutaminase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Transglutaminases: crosslinking enzymes with pleiotropic functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

The HIF pathway in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Integrating cell-signalling pathways with NF-kappaB and IKK function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Is HIF-1alpha a pro- or an anti-apoptotic protein?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Hypoxia signalling in cancer and approaches to enforce tumour regression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Targeting HIF-1 for cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

TGFbeta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Tissue transglutaminase-mediated chemoresistance in cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Tissue transglutaminase serves as an inhibitor of apoptosis by cross-linking caspase 3 in thapsigargin-treated cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Expression of hypoxia-inducible factor 1? in brain tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

Identification of differentially expressed proteins in human glioblastoma cell lines and tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

COX-2–Dependent Cardiac Failure in Gh/tTG Transgenic Mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.342

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.342

1 reference

Dimensions Publication ID

14 September 2017

0 references

1 reference